Venture Investment & Partnering (VIP) Forums
One of the WBBA’s objectives is to assist life science companies, entrepreneurs and researchers in bridging the gap between discovery and commercialization. To this end, WBBA has an exciting program called Venture Investment & Partnering (VIP) Forums. VIP Forums present a unique opportunity for local life science entrepreneurs, companies and researchers to meet with quality investors and strategic partners. We invite venture capital firms, corporate venture groups and multinational strategics (VIPs) to Seattle for a two-part event.
First, WBBA hosts a Plenary Session during which the VIP discusses their targets, interests, and investment/partnering strategies, and answers questions from the audience. The Plenary Session is followed by a networking reception. Second, pre-selected organizations present their investment and partnering opportunities to the VIP in a one-on-one setting.
Previous VIPs include LongTech Medical, Johnson & Johnson Development Corp.,Shire Pharmaceuticals, C.R. Bard, MedImmune Ventures and Partnering, H.I.G. BioVentures, Bristol-Myers Squibb, Bayer Healthcare, Merck Global Health Innovation, Takeda Ventures, Johnson & Johnson’s COSAT, BioWa, Inc., Essex Woodlands, NEA and OrbiMed.
Upcoming VIP Forum
December 5-6, 2013: Novo Nordisk
Novo Nordisk is a global healthcare company with 90 years of innovation and leadership in diabetes care. The company also has leading positions within haemophilia care, growth hormone replacement therapy, and hormone repacement theraphy. Companies, entrepreneurs and research groups developing technologies in the following areas are encouraged to apply for a one-on-one meeting with Novo Nordisk business development executives:
- Diabetes & protein technologies
- Autoimmune inflammatory diseases
- Protein delivery devices
For more on specific partnering focus, see Novo Nordisk's Partnering Brochure.
Join us for a Plenary Session with Novo Nordisk on December 5th from 5-7 PM to learn about partnering with Novo. This event is free and open to all.
To apply to meet one-on-one with executives from Novo Nordisk Business Development, send a two-page executive summary to firstname.lastname@example.org by November 20th, 5 PM.
There are no fees associated with this event; companies chosen for 1:1 meetings MUST be WBBA members.
VIP Forums are made possible by the partnership and generous support of:
If you have questions or are interested in visiting Seattle as a VIP or sponsoring VIP Forums, please contact email@example.com
Recent VIP Forums
September 27-30 with LongTech Medical Technology
May 16-17: Johnson & Johnson Development Corp.
January 10: Bristol-Myers Squibb
December 5-6: Shire Pharmaceuticals
August 6-7: C.R. Bard
May 23-24, 2012: MedImmune Ventures & MedImmune Partnering
March 7-8, 2012: H.I.G. BioVentures